BIOMAT Database Logo BIOMAT Database Logo

Molecular characterization of beta-thalassemia in Hungary. 1993

B Ringelhann, and J G Szelenyi, and M Horanyi, and M Svobodova, and V Divoky, and K Indrak, and S Hollân, and A Marosi, and M Laub, and T H Huisman
Trencseni ut 39/b, Budapest, Hungary.

We have identified seven different beta-thalassemia mutations and one delta beta-thalassemia determinant (the Sicilian type) in 32 members of 17 Hungarian families. The most common mutation is the IVS-I-1 (G-->A) change; its high frequency is comparable to that observed in neighboring Czechoslovakia. Additional mutations are of Mediterranean origin. One rare mutation (initiation codon ATG-->GTG) was identified as an independent mutation because of the absence of known polymorphisms in the beta-globin gene. One new frameshift at codon 51 (-C) was observed in a single individual; hematological data were as expected for a beta zero-thalassemia heterozygosity.

UI MeSH Term Description Entries
D008967 Molecular Biology A discipline concerned with studying biological phenomena in terms of the chemical and physical interactions of molecules. Biochemical Genetics,Biology, Molecular,Genetics, Biochemical,Genetics, Molecular,Molecular Genetics,Biochemical Genetic,Genetic, Biochemical,Genetic, Molecular,Molecular Genetic
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D003062 Codon A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). Codon, Sense,Sense Codon,Codons,Codons, Sense,Sense Codons
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005914 Globins A superfamily of proteins containing the globin fold which is composed of 6-8 alpha helices arranged in a characterstic HEME enclosing structure. Globin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006814 Hungary A country in Europe, northwest of Romania, south of Slovakia, and east of Austria. The capital is Budapest.
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D015345 Oligonucleotide Probes Synthetic or natural oligonucleotides used in hybridization studies in order to identify and study specific nucleic acid fragments, e.g., DNA segments near or within a specific gene locus or gene. The probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the probe include the radioisotope labels 32P and 125I and the chemical label biotin. Oligodeoxyribonucleotide Probes,Oligonucleotide Probe,Oligoribonucleotide Probes,Probe, Oligonucleotide,Probes, Oligodeoxyribonucleotide,Probes, Oligonucleotide,Probes, Oligoribonucleotide

Related Publications

B Ringelhann, and J G Szelenyi, and M Horanyi, and M Svobodova, and V Divoky, and K Indrak, and S Hollân, and A Marosi, and M Laub, and T H Huisman
[Beta-thalassemia major in Hungary].
November 1976, Orvosi hetilap,
B Ringelhann, and J G Szelenyi, and M Horanyi, and M Svobodova, and V Divoky, and K Indrak, and S Hollân, and A Marosi, and M Laub, and T H Huisman
[Incidence of beta-thalassemia in Hungary].
January 1976, Orvosi hetilap,
B Ringelhann, and J G Szelenyi, and M Horanyi, and M Svobodova, and V Divoky, and K Indrak, and S Hollân, and A Marosi, and M Laub, and T H Huisman
Beta-thalassemia in China: a systematic molecular characterization of beta-thalassemia mutations.
January 1988, Hemoglobin,
B Ringelhann, and J G Szelenyi, and M Horanyi, and M Svobodova, and V Divoky, and K Indrak, and S Hollân, and A Marosi, and M Laub, and T H Huisman
Molecular characterization of beta-thalassemia in Pakistan.
July 1998, Hemoglobin,
B Ringelhann, and J G Szelenyi, and M Horanyi, and M Svobodova, and V Divoky, and K Indrak, and S Hollân, and A Marosi, and M Laub, and T H Huisman
Molecular characterization of beta-thalassemia in Syria.
February 2000, Hemoglobin,
B Ringelhann, and J G Szelenyi, and M Horanyi, and M Svobodova, and V Divoky, and K Indrak, and S Hollân, and A Marosi, and M Laub, and T H Huisman
Molecular characterization of beta-thalassemia in Azerbaijan.
December 1992, Human genetics,
B Ringelhann, and J G Szelenyi, and M Horanyi, and M Svobodova, and V Divoky, and K Indrak, and S Hollân, and A Marosi, and M Laub, and T H Huisman
Molecular characterization of beta-thalassemia in Czechoslovakia.
February 1992, Human genetics,
B Ringelhann, and J G Szelenyi, and M Horanyi, and M Svobodova, and V Divoky, and K Indrak, and S Hollân, and A Marosi, and M Laub, and T H Huisman
Molecular characterization of beta-thalassemia in Egyptians.
January 1993, Human mutation,
B Ringelhann, and J G Szelenyi, and M Horanyi, and M Svobodova, and V Divoky, and K Indrak, and S Hollân, and A Marosi, and M Laub, and T H Huisman
Molecular characterization of beta-thalassemia mutations in Egypt.
August 1990, Human genetics,
B Ringelhann, and J G Szelenyi, and M Horanyi, and M Svobodova, and V Divoky, and K Indrak, and S Hollân, and A Marosi, and M Laub, and T H Huisman
Molecular characterization of beta-thalassemia in north Jordan.
September 1994, Hemoglobin,
Copied contents to your clipboard!